Investor Relations Report Governance Furthermore, the IR team met the buy-side and sell-side analysts on around 350 occasions and participated in more than 10 Non-Deal Roadshows (NDR) and conferences across the year. The Group also received mainstream media coverage in Malaysia, Singapore and other markets. No. Equity Research Firms Covering IHH in 2023 1 Affin Securities Sdn Bhd 2 AmInvestment Bank Berhad 3 Bank of America Merrill Lynch Global Research 4 BIMB Securities Sdn Bhd 5 CIMB Securities Pte Ltd 6 CLSA Limited 7 DBS Vickers Securities 8 Goldman Sachs India Sec Pte Ltd 9 Hong Leong Investment Bank Bhd 10 J.P. Morgan Securities (Malaysia) Sdn Bhd 11 K&N Kenanga Holdings Bhd 12 Macquarie Securities Ltd 13 Maybank Kim Eng Securities 14 MIDF Amanah Investment Bank Bhd 15 Morgan Stanley Asia (Singapore) Pte Ltd 16 Nomura Securities Co Ltd/Tokyo 17 Public Investment Bank 18 RHB Research Institute Sdn Bhd 19 TA Securities Holdings Bhd 20 UBS Securities Malaysia Sdn Bhd 21 UOB Kay Hian Pte Ltd Awards Among the awards received in 2023, we were notably recognised for our strong leadership and excellence in engaging with investors, receiving seven accolades in Institutional Investor’s 2023 All-Asia (ex-Japan) Executive Team rankings. IHH was in the top 3 across all seven categories for Asia: ‘Best CEO’, ‘Best CFO’, ‘Overall ESG’, ‘Best Investor Relations’, ‘Best IR team’, ‘Company Board of Directors’, and ‘IR Professional’. Additionally, IHH clinched the ‘Most Honored Companies – Rest of Asia’ award. IHH Website and Social Media All our stakeholders are able to access essential information about IHH via our corporate website. The site contains IHH’s corporate profile, profiles of Board Members and Senior Management, as well as the IR section which serves as a one-stop destination for shareholders, investors, and analysts to find information of interest, such as share prices, quarterly results briefing presentation decks, annual reports, dividend policy, Annual General Meeting, and more. We also share highlights, achievements and other interesting Group updates via IHH Healthcare’s LinkedIn and Telegram accounts. Quarterly Analyst Briefings Every quarter, IHH’s Senior Management will communicate the company’s performance through our quarterly analyst briefings. These briefings are live-streamed and Senior Management will address the questions asked mainly by the sell-side analysts in those sessions. These quarterly results materials are made available on the IR section of the IHH website: • Press release highlighting key operational and financial highlights • Consolidated quarterly financial report • Presentation slides with operational and financial data • Recording of the briefing sessions for the past 4 quarters Analyst Coverage IHH has continued to attract strong interest from domestic and international equity research houses. As of 31 December 2023, the Group received coverage from 21 analysts. A total of 1,025 companies received votes in this year’s Asia Pacific (ex-Japan) Executive Team - Rest of Asia survey. This came from voting results by a record high of 5,660 buy-side and 814 sell-side analysts this year and is testament to the ongoing, proactive engagement with our stakeholders. Dividend Distribution IHH recently revised its dividend policy from ‘no less than 20%’ to ‘no less than 30%’ of the Group’s profit after tax and minority interest (excluding exceptional items) to be distributed to the Group’s shareholders in each financial year. This demonstrates our disciplined approach to have our shareholders participate in IHH’s success and growth. Total dividend of 18.6 sen was declared with respect to FY2023, comprising an interim dividend of 3.5 sen paid on 27 October 2023, a special cash dividend of 9.6 sen from the sale of IMU paid on 30 June 2023, and a final dividend of 5.5 sen paid on 26 April 2024. The following factors guide the Board of Directors in considering dividend payments: (i) the amount of cash and cash equivalents the Group has available (ii) its return on equity and retained earnings (iii) the projected levels of capital expenditure and other investment plan IR Policy Board members endorse our IR policy, which is designed to ensure comprehensive communications processes with stakeholders. IHH Healthcare Berhad 120
RkJQdWJsaXNoZXIy NDgzMzc=